Belantamab mafodotin Antibody

SKU: orb2279041

Description

Belantamab mafodotin (GSK2857916) is a BCMA-targeting antibody-drug conjugate for multiple myeloma research. It promotes immune cell activity within tumors and inhibits tumor progression, making it applicable for both in vitro mechanistic studies and in vivo xenograft models of hematological malignancies.

Key Properties

• Target: Antibody-Drug Conjugates (ADCs)
• Molecular Weight: 146.06 kDa
• Purity: 99.14% (May vary between batches)
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Concentration: 7.98 mg/mL
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

ADCs, AntibodyDrugConjugates(ADCs), AntibodyDrugConjugates, AntibodyDrug Conjugates (ADCs), Antibody-Drug Conjugates, Belantamab mafodotin, Belantamab mafodotin-blm, GSK2857916, GSK-2857916, GSK 2857916

Quick Database Links

Gene Symbol

Antibody-Drug Conjugates (ADCs)